| Date Filed | Type | Description |
| 02/14/2014 |
SC 13G/A
| KPCB PANDEMIC & BIO DEFENSE FUND LLC reports a 0% stake in Trius Therapeutics, Inc. |
| 09/13/2013 |
4
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| EASTHAM KARIN (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 6,000 shares
@ $0
Disposed/sold 12,114 shares
@ $0
Disposed/sold 17,441 options to buy
@ $7.57, valued at
$132k
Disposed/sold 6,000 options to buy
@ $3.5, valued at
$21k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| O'Leary Brendan (Director) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| Schmid John P. (CFO) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| TRUEX PAUL F (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 11,270 shares
@ $0
Disposed/sold 12,403 options to buy
@ $1.29, valued at
$16k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| MORNEAU MICHAEL (VP Finance & CAO) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| Stein Jeffrey (President & CEO) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 210,457 shares
@ $0
Disposed/sold 81,280 options to buy
@ $0.52, valued at
$42.3k
Disposed/sold 156,976 options to buy
@ $1.29, valued at
$202.5k
Disposed/sold 30,813 options to buy
@ $1.29, valued at
$39.7k
Disposed/sold 200,000 options to buy
@ $3.5, valued at
$700k
Disposed/sold 250,000 options to buy
@ $4.8, valued at
$1.2M
Disposed/sold 275,000 options to buy
@ $6.13, valued at
$1.7M
|
|
| 09/13/2013 |
4
| KABAKOFF DAVID S (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 5,285 shares
@ $0
Disposed/sold 106,081 shares
@ $0
Disposed/sold 18,000 options to buy
@ $3.5, valued at
$63k
Disposed/sold 18,000 options to buy
@ $8.26, valued at
$148.7k
Disposed/sold 18,000 options to buy
@ $5.05, valued at
$90.9k
Disposed/sold 21,000 options to buy
@ $7.77, valued at
$163.2k
|
|
| 09/13/2013 |
4
| Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 100,000 options to buy
@ $7.67, valued at
$767k
|
|
| 09/13/2013 |
4
| Fischer Seth H.Z. (Director) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 9,302 options to buy
@ $1.29, valued at
$12k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| Kjellson Nina S (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 9,302 options to buy
@ $1.29, valued at
$12k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| Schroeder Theodore R (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 15,116 options to buy
@ $7.57, valued at
$114.4k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
SC 13D/A
| CUBIST PHARMACEUTICALS INC has filed a Schedule 13D for Trius Therapeutics Inc |
| 09/11/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/11/2013 |
8-K
| Quarterly results |
| 09/11/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/11/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 09/05/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/03/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/29/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/26/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 08/14/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/13/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 08/13/2013 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 08/09/2013 |
SC 13D
| Trius Therapeutics Inc reports a 27.5% stake in TRIUS THERAPEUTICS, INC. |
| 08/07/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 08/06/2013 |
8-K
| Quarterly results |
| 08/02/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 08/01/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
|